AI assistant
Replimune Group, Inc. — Director's Dealing 2023
Sep 14, 2023
33193_dirs_2023-09-13_b4a14723-2885-4b16-8c7d-0e1615a0e5e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-09-11
Reporting Person: Esposito Pamela (Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-11 | Common Stock | M | 5358 | $3.30 | Acquired | 268794 | Direct |
| 2023-09-11 | Common Stock | S | 5358 | $20.01 | Disposed | 263436 | Direct |
| 2023-09-12 | Common Stock | M | 300 | $3.30 | Acquired | 263736 | Direct |
| 2023-09-12 | Common Stock | S | 300 | $20.00 | Disposed | 263436 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | Employee Stock Option (right to buy) | $3.30 | M | 5358 | Disposed | 2027-07-26 | Common Stock (5358) | Direct |
| 2023-09-12 | Employee Stock Option (right to buy) | $3.30 | M | 300 | Disposed | 2027-07-26 | Common Stock (300) | Direct |
Footnotes
F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.05. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 491,569 shares of the Issuer's common stock, 376,774 of which are exercisable as of the date hereof.
F4: The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.